Correspondence on “The role of clinical response to treatment in determining pathogenicity of genomic variants” by Shen et al.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Shen JJ, Wortmann SB, de Boer L, et al. The role of clinical response to treatment in determining pathogenicity of genomic variants. Genet Med. 2020 Oct 22; https://doi.org/10.1038/s41436-020-00996-9 [Epub ahead of print].

  2. 2.

    Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424.

    Article  Google Scholar 

  3. 3.

    Tavtigian SV, Greenblatt MS, Harrison SM, et al. Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet Med. 2018;20:1054–1060.

    Article  Google Scholar 

  4. 4.

    Tavtigian SV, Harrison SM, Boucher KM, Biesecker LG. Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines. Hum Mutat. 2020 Jul 27; https://doi.org/10.1002/humu.24088 [Epub ahead of print].

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Leslie G. Biesecker MD.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Biesecker, L.G., Harrison, S.M. & Rehm, H.L. Correspondence on “The role of clinical response to treatment in determining pathogenicity of genomic variants” by Shen et al.. Genet Med (2020). https://doi.org/10.1038/s41436-020-01032-6

Download citation

Search